Valuation Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. 20/08/2026			5-day change	1st Jan Change
977.30 ^PKR	-0.59%		-2.61%	-4.42%

19/05	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI
30/04	Highnoon Laboratories Limited Approves Final Cash Dividend for the Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2024	2025	2026	2027	2028
Market Cap ¹	48,650	54,175	52,317	-	-
Change	-	11.36%	-3.43%	-	-
Enterprise Value (EV)	48,650	54,175	52,317	52,317	52,317
Change	-	11.36%	-3.43%	0%	0%
P/E	14.4x	-	-	-	-
PBR	-	-	-	-	-
PEG	-	-	-	-	-
Capitalization / Revenue	-	1.96x	1.72x	1.53x	1.36x
EV / Revenue	-	0x	1.72x	1.53x	1.36x
EV / EBITDA	-	-	-	-	-
EV / EBIT	-	-	-	-	-
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	50	45	52	60
Rate of return	-	4.89%	4.6%	5.32%	6.14%
EPS ²	63.95	-	-	-	-
Distribution rate	-	-	-	-	-
Net sales ¹	-	27,706	30,398	34,163	38,399
EBITDA	-	-	-	-	-
EBIT	-	-	-	-	-
Net income	3,389	-	-	-	-
Net Debt	-	-	-	-	-
Reference price ²	918.22	1,022.49	977.30	977.30	977.30
Nbr of stocks (in thousands)	52,983	52,983	52,983	-	-
Announcement Date	26/03/25	07/04/26	-	-	-

¹PKR in Million²PKR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HIGHNOON LABORATORIES LIMITED	-	-	-	4.6%	19Cr
ELI LILLY AND COMPANY	35.55x	12.84x	26.06x	0.55%	1,10900Cr
JOHNSON & JOHNSON	29.74x	-	-	2.01%	64TCr
ABBVIE INC.	33.42x	7.74x	16.11x	2.62%	46TCr
ROCHE HOLDING AG	20.72x	4.91x	12.16x	2.69%	37TCr
NOVARTIS AG	22.47x	5.78x	14.33x	2.76%	30TCr
ASTRAZENECA PLC	21.12x	4.35x	12.35x	2.02%	26TCr
AMGEN INC.	27.43x	7.09x	12.59x	2.33%	23TCr
NOVO NORDISK A/S	13.47x	4.79x	10.05x	3.81%	20TCr
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	18TCr
Average	17.79x	6.73x	16.05x	2.57%	37.61TCr
Weighted average by Cap.	25.34x	8.43x	18.53x	1.91%